BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 29150884)

  • 1. Directional local field potentials: A tool to optimize deep brain stimulation.
    Tinkhauser G; Pogosyan A; Debove I; Nowacki A; Shah SA; Seidel K; Tan H; Brittain JS; Petermann K; di Biase L; Oertel M; Pollo C; Brown P; Schuepbach M
    Mov Disord; 2018 Jan; 33(1):159-164. PubMed ID: 29150884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local Field Potentials Predict Motor Performance in Deep Brain Stimulation for Parkinson's Disease.
    Busch JL; Kaplan J; Bahners BH; Roediger J; Faust K; Schneider GH; Florin E; Schnitzler A; Krause P; Kühn AA
    Mov Disord; 2023 Dec; 38(12):2185-2196. PubMed ID: 37823518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraoperative Local Field Potential Beta Power and Three-Dimensional Neuroimaging Mapping Predict Long-Term Clinical Response to Deep Brain Stimulation in Parkinson Disease: A Retrospective Study.
    di Biase L; Piano C; Bove F; Ricci L; Caminiti ML; Stefani A; Viselli F; Modugno N; Cerroni R; Calabresi P; Bentivoglio AR; Tufo T; Di Lazzaro V;
    Neuromodulation; 2023 Dec; 26(8):1724-1732. PubMed ID: 36774326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subthalamic local field beta oscillations during ongoing deep brain stimulation in Parkinson's disease in hyperacute and chronic phases.
    Rosa M; Giannicola G; Servello D; Marceglia S; Pacchetti C; Porta M; Sassi M; Scelzo E; Barbieri S; Priori A
    Neurosignals; 2011; 19(3):151-62. PubMed ID: 21757872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term recordings of local field potentials from implanted deep brain stimulation electrodes.
    Abosch A; Lanctin D; Onaran I; Eberly L; Spaniol M; Ince NF
    Neurosurgery; 2012 Oct; 71(4):804-14. PubMed ID: 22791039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of optimal programming contacts based on local field potential recordings from subthalamic nucleus in patients with Parkinson's disease.
    Ince NF; Gupte A; Wichmann T; Ashe J; Henry T; Bebler M; Eberly L; Abosch A
    Neurosurgery; 2010 Aug; 67(2):390-7. PubMed ID: 20644424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subthalamic beta dynamics mirror Parkinsonian bradykinesia months after neurostimulator implantation.
    Steiner LA; Neumann WJ; Staub-Bartelt F; Herz DM; Tan H; Pogosyan A; Kuhn AA; Brown P
    Mov Disord; 2017 Aug; 32(8):1183-1190. PubMed ID: 28639263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of subthalamic nucleus local field potentials recordings in predicting stimulation parameters for deep brain stimulation in Parkinson's disease.
    Yoshida F; Martinez-Torres I; Pogosyan A; Holl E; Petersen E; Chen CC; Foltynie T; Limousin P; Zrinzo LU; Hariz MI; Brown P
    J Neurol Neurosurg Psychiatry; 2010 Aug; 81(8):885-9. PubMed ID: 20466699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term directional deep brain stimulation: Monopolar review vs. local field potential guided programming.
    Fernández-García C; Monje MHG; Gómez-Mayordomo V; Foffani G; Herranz R; Catalán MJ; González-Hidalgo M; Matias-Guiu J; Alonso-Frech F
    Brain Stimul; 2022; 15(3):727-736. PubMed ID: 35490971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correspondence of optimal stimulation and beta power varies regionally in STN DBS for Parkinson disease.
    Lu CW; Chou KL; Patil PG
    Parkinsonism Relat Disord; 2020 Sep; 78():124-128. PubMed ID: 32814231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraoperative local field recording for deep brain stimulation in Parkinson's disease and essential tremor.
    Holdefer RN; Cohen BA; Greene KA
    Mov Disord; 2010 Oct; 25(13):2067-75. PubMed ID: 20721922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biophysical characterization of local field potential recordings from directional deep brain stimulation electrodes.
    Noor MS; McIntyre CC
    Clin Neurophysiol; 2021 Jun; 132(6):1321-1329. PubMed ID: 33867263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining Multimodal Biomarkers to Guide Deep Brain Stimulation Programming in Parkinson Disease.
    Shah A; Nguyen TK; Peterman K; Khawaldeh S; Debove I; Shah SA; Torrecillos F; Tan H; Pogosyan A; Lachenmayer ML; Michelis J; Brown P; Pollo C; Krack P; Nowacki A; Tinkhauser G
    Neuromodulation; 2023 Feb; 26(2):320-332. PubMed ID: 35219571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gait-related frequency modulation of beta oscillatory activity in the subthalamic nucleus of parkinsonian patients.
    Canessa A; Palmisano C; Isaias IU; Mazzoni A
    Brain Stimul; 2020; 13(6):1743-1752. PubMed ID: 32961337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pain-Induced Beta Activity in the Subthalamic Nucleus of Parkinson's Disease.
    Parker T; Huang Y; Gong C; Chen Y; Wang S; Green AL; Aziz T; Li L
    Stereotact Funct Neurosurg; 2020; 98(3):193-199. PubMed ID: 32348997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low beta-band suppression as a tool for DBS contact selection for akinetic-rigid symptoms in Parkinson's disease.
    Strelow JN; Dembek TA; Baldermann JC; Andrade P; Fink GR; Visser-Vandewalle V; Barbe MT
    Parkinsonism Relat Disord; 2023 Jul; 112():105478. PubMed ID: 37331065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Directional deep brain stimulation of the subthalamic nucleus: A pilot study using a novel neurostimulation device.
    Steigerwald F; Müller L; Johannes S; Matthies C; Volkmann J
    Mov Disord; 2016 Aug; 31(8):1240-3. PubMed ID: 27241197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local field potential activity dynamics in response to deep brain stimulation of the subthalamic nucleus in Parkinson's disease.
    Wiest C; Tinkhauser G; Pogosyan A; Bange M; Muthuraman M; Groppa S; Baig F; Mostofi A; Pereira EA; Tan H; Brown P; Torrecillos F
    Neurobiol Dis; 2020 Sep; 143():105019. PubMed ID: 32681881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sixty-hertz stimulation improves bradykinesia and amplifies subthalamic low-frequency oscillations.
    Blumenfeld Z; Koop MM; Prieto TE; Shreve LA; Velisar A; Quinn EJ; Trager MH; Brontë-Stewart H
    Mov Disord; 2017 Jan; 32(1):80-88. PubMed ID: 27859579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuromodulation targets pathological not physiological beta bursts during gait in Parkinson's disease.
    Anidi C; O'Day JJ; Anderson RW; Afzal MF; Syrkin-Nikolau J; Velisar A; Bronte-Stewart HM
    Neurobiol Dis; 2018 Dec; 120():107-117. PubMed ID: 30196050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.